洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR-OIC-16007974】Ultrasound-guided Multi-level Thoracic Paravertebral Block at three levels (T1, T3, and T5) in Combination with a pectoral nerve block for surgical anaesthesia during major breast cancer surgery: A Prospective Feasibility study

基本信息
登记号

ChiCTR-OIC-16007974

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2016-02-22

临床申请受理号

/

靶点

/

适应症

乳腺癌

试验通俗题目

Ultrasound-guided Multi-level Thoracic Paravertebral Block at three levels (T1, T3, and T5) in Combination with a pectoral nerve block for surgical anaesthesia during major breast cancer surgery: A Prospective Feasibility study

试验专业题目

Ultrasound-guided Multi-level Thoracic Paravertebral Block at three levels (T1, T3, and T5) in Combination with a pectoral nerve block for surgical anaesthesia during major breast cancer surgery: A Prospective Feasibility study

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

To evaluate the feasibility of using 3 paravertebral injections (3m-TPVB) at T1, T3 and T5 instead of the traditional 6 injections (at T1 to T6)that are performed in combination with a PECS block for surgical anesthesia in patients undergoing major breast cancer surgery.

试验分类
试验类型

单臂

试验分期

Ⅳ期

随机化

NA

盲法

/

试验项目经费来源

Department of Anaesthesia & Intensive Care, CUHK

试验范围

/

目标入组人数

30

实际入组人数

/

第一例入组时间

1990-01-01

试验终止时间

1990-01-01

是否属于一致性

/

入选标准

Adult patients, ASA physical status I-III, aged between 30 to 80 years scheduled to undergo modified radical mastectomy (MRM) or mastectomy with sentinel lymph node biopsy will be recruited.;

排除标准

Patient refusal, ASA physical status >III, BMI > 35kg/m2, spinal deformity, previous spine surgery, pregnancy, coagulopathy, allergy to local anesthetic drugs, and skin infection at the site of needle insertion will be excluded.;

研究者信息
研究负责人姓名
试验机构

Department of Anaesthesia & Intensive Care, CUHK

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

最新临床资讯